A screening test employed to identify cervical dysplasia, which refers to abnormal cellular changes in the cervix that may potentially progress into cancer, is known as a cervical smear test. This test is also capable of detecting viral infections of the cervix, including herpes simplex, papilloma, and Chlamydia Trachomatis.
It is recommended that a cervical smear test be conducted within six months of a woman’s initial engagement in sexual intercourse. A follow-up test may be conducted between six and twelve months thereafter. In the absence of any identified abnormalities in these tests, subsequent screenings should be scheduled at approximately three-year intervals until the age of 65.
Cervical smear tests are typically conducted by doctors or nurses at general practice clinics or sexual health clinics. During the procedure, a small sample of cells is collected from the surface of the cervix using a spatula or a specialized brush. The collected cells are then examined under a microscope. If all the cells appear normal, no further action is necessary. However, if any cells indicate dysplasia, the severity of the condition will be assessed, and additional smear tests and investigations, such as colposcopy (a procedure to visually inspect the cervix using a viewing instrument), may be required.